GlassScriptPhysician profile
Joah Aliancy
NPI 1083155295
$7,125.45
in general payments reported to CMS, 2019-2025
16 companies · $5,042 in 2025
The $5,042 reported for 2025 was more than what 89% of Glaucoma Specialist providers received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.38 · 2022: $381 · 2023: $599 · 2024: $1,087 · 2025: $5,042.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,842 · Consulting Fee: $825 · Education: $61.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,841.76 |
| Consulting Fee | $825.00 |
| Education | $61.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $1,697.55 | 2025 | M22 |
| Glaukos Corporation | $1,470.94 | 2022-2025 | Idose, Idosetr, Istent Infinite |
| Abbvie INC. | $1,365.72 | 2022-2025 | Durysta, Xen Glaucoma Treatment System, Lumigan |
| Alcon Vision LLC | $1,025.94 | 2022-2025 | Hydrus Microstent, Rocklatan, Simbrinza |
| Sight Sciences, INC. | $615.48 | 2023-2025 | Omni Surgical System |
| New World Medical,INC. | $342.47 | 2024-2025 | Kahook Dual Blade, Ahmed Glaucoma Valve, Streamline |
| Rayner Intraocular Lenses Limited | $124.11 | 2024-2025 | Omidria, Rayone Spheric, Rayone Emv |
| Ocular Therapeutix, INC. | $122.92 | 2023-2025 | Dextenza |
| Oyster Point Pharma, INC. | $91.72 | 2025 | Tyrvaya, Ryzumvi |
| Bausch & Lomb Americas INC. | $87.39 | 2022-2024 | Envista Mx60 Iol, Xiidra |
| Harrow Eye, LLC | $73.34 | 2025 | |
| Biotissue Holdings INC. | $33.02 | 2025 | |
| Tarsus Pharmaceuticals, INC. | $29.18 | 2024 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $16.38 | 2021 | |
| Ziemer USA | $14.70 | 2025 | Femtoldv, Galilei |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumibird Medical INC. | $14.59 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joah Aliancy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.